Meda AB
 | |
| OTCPK:MDABY | |
| Headquarters | Solna, Sweden |
| Revenue | >kr 15,000,000,000 (2014) |
Number of employees | 5,202 (2014) |
| Website |
www |
Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are sold in more than 150 countries.[1]
Meda was listed on the Stockholm stock market until it was acquired by Mylan in 2016 through a cash and stock offer.
Mergers, acquisitions and divestments
In 2014, Meda acquired the Italian firm RottaPharm Madaus in order to add consumer health products to their portfolio.[2] Meda explored in 2015 the possibility of divesting its United States division, Meda Pharmaceuticals, to raise funds for expansion in other areas.[2]
| Meda |
| |||||||||
References
- ↑ "About Meda". Meda AB. Retrieved 15 August 2015.
- 1 2 Ewing, Adam; Baigorri, Manuel (27 August 2015). "Swedish Drugmaker Meda Said to Weigh Sale of U.S. Operations". Bloomberg Business. Retrieved 28 August 2015.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.